The purpose of the present invention is to provide a therapeutic and/or prophylactic agent, said agent targeting human Orai1, for transplant rejection, immunopathies, allergic diseases, inflammatory diseases, thrombi, cancers, etc.Provided are a medicinal composition, etc. comprising an antibody that has an activity of specifically recognizing human Orai1 and suppressing human T cell activation.